Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of biomarkers and imaging in Parkinson's disease.

Expert review of neurotherapeutics - 1 Jan 2016

Algarni Musleh A, Stoessl A Jon

Abstract excerpt

The diagnosis of Parkinson's disease (PD) currently relies on the appearance of certain clinical features. However, these features appear only years after the loss of nigral dopaminergic neurons. The progression of PD may be measured using clinical rating scales that are subjective and that have a variable inter-rater consistency. There is a growing need for a biomarker that will allow for early detection of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diffusion Tensor Imaging
Share to Dopaminergic Neurons
Share to Functional Neuroimaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neuroimaging

Share to Oncogene Proteins

Share to Protein Deglycase DJ-1

Share to Substantia Nigra

Share to Tomography, Emission-Computed, Single-Photon

Source

Identifiers

PMID: 26829357
DOI: 10.1586/14737175.2016.1135056

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of biomarkers and imaging in Parkinson's disease.PMID 26829357Read ↗

Neuroimaging Biomarkers in Parkinson's Disease: Current Applications and Future DirectionsSemantic proximity Read ↗

Parkinson's disease--the continuing search for biomarkers.Semantic proximity Read ↗

Diagnostic biomarkers for Parkinson's disease at a glance: where are we?Semantic proximity Read ↗

Biomarkers in Huntington's and Parkinson's Disease.Semantic proximity Read ↗

From phenotype to biology: a multi-modal roadmap of biofluid, tissue, imaging, and digital biomarkers in Parkinson's disease.Semantic proximity Read ↗

Molecular imaging in hereditary forms of parkinsonism.Semantic proximity Read ↗

Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.Semantic proximity Read ↗

Differences in Blood and Cerebrospinal Fluid Between Parkinson’s Disease and Related DiseasesSemantic proximity Read ↗

[Imaging of genetic aspects of Parkinson's disease].Semantic proximity Read ↗

APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.Semantic proximity Read ↗

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease.Semantic proximity Read ↗

The challenges with the identification of Parkinson's disease subtypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.